Cell line and process development
Celltheon provides these services using its SMART™ Platform and expertise, with a focus on difficult-to-express therapeutic proteins.
Source: LinkedIn company description · Retrieved October 13, 2026
Celltheon is a San Francisco Bay Area company that has developed cell engineering technologies since 2012.
Celltheon holds granted and pending patents for its CHOK-1-derived SUPERCELL™ cell line and DNA and RNA vector elements.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The CELLTHEON SMART™ Platform has been used in biotherapeutics programs for oncology, neurobiology, and rheumatoid arthritis.
Celltheon provides these services using its SMART™ Platform and expertise, with a focus on difficult-to-express therapeutic proteins.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.